Eli Lilly & Co
LLY
Revenue
11.44B
▲136.30M▲1.21%
3 Months ChangeAssets
75.61B
▲3.73B▲5.19%
3 Months ChangeLiabilities
61.37B
▲3.05B▲5.24%
3 Months ChangeFree Cash Flow
2.16B
▲760.50M▲54.43%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 10-Q
ID: 0000059478-24-000245
2024-10-30
Form 8-K
ID: 0000059478-24-000242
2024-09-09
Form 8-K
ID: 0000059478-24-000213
2024-08-16
Form 8-K
ID: 0000059478-24-000196
2024-08-14
Form 8-K
ID: 0001193125-24-200435
2024-08-08
Form 10-Q
ID: 0000059478-24-000187
2024-08-08
Form 8-K
ID: 0000059478-24-000185
2024-07-10
Form 8-K
ID: 0000059478-24-000164
2024-06-05
Form 8-K
ID: 0000059478-24-000146
2024-05-09
Form 8-K
ID: 0000059478-24-000127